{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:05:52Z","timestamp":1779192352717,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovative Research Team Project of Guangxi Natural Science Foundation","award":["2025GXNSFGA069002"],"award-info":[{"award-number":["2025GXNSFGA069002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04803-1","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:32:21Z","timestamp":1774420341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical epidemiology and risk prediction of unsuccessful treatment outcomes in pulmonary tuberculosis with diabetes mellitus"],"prefix":"10.1186","volume":"24","author":[{"given":"Ping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feilong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhong","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenglin","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"1","key":"4803_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/s2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20. https:\/\/doi.org\/10.1016\/s2666-5247(22)00359-7.","journal-title":"Lancet Microbe"},{"key":"4803_CR2","doi-asserted-by":"publisher","unstructured":"Lv H, Wang L, Zhang X, Dang C, Liu F, Zhang X, et al. Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data. Infect Dis Poverty. 2024;13(1). https:\/\/doi.org\/10.1186\/s40249-024-01247-8.","DOI":"10.1186\/s40249-024-01247-8"},{"issue":"11","key":"4803_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078924","volume":"8","author":"MC Kuo","year":"2013","unstructured":"Kuo MC, Lin SH, Lin CH, Mao IC, Chang SJ, Hsieh MC. Type 2 diabetes: an independent risk factor for tuberculosis: a nationwide population-based study. PLoS ONE. 2013;8(11):e78924. https:\/\/doi.org\/10.1371\/journal.pone.0078924.","journal-title":"PLoS ONE"},{"key":"4803_CR4","doi-asserted-by":"publisher","unstructured":"Franco JVA, Bongaerts B, Metzendorf M-I, Risso A, Guo Y, Pe\u00f1a Silva L, et al. Diabetes as a risk factor for tuberculosis disease. Cochrane Database System Rev. 2024;2025(2). https:\/\/doi.org\/10.1002\/14651858.CD016013.pub2.","DOI":"10.1002\/14651858.CD016013.pub2"},{"issue":"2","key":"4803_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/trstmh\/try124","volume":"113","author":"S Dunachie","year":"2019","unstructured":"Dunachie S, Chamnan P. The double burden of diabetes and global infection in low and middle-income countries. Trans R Soc Trop Med Hyg. 2019;113(2):56\u201364. https:\/\/doi.org\/10.1093\/trstmh\/try124.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4803_CR6","doi-asserted-by":"publisher","unstructured":"Lee H, Kim J, Kim J, Park YJ. Review of the global burden of tuberculosis in 2023: insights from the WHO Global Tuberculosis Report 2024. Jugan Geongang Gwa Jilbyeong. 2025;18(11 Suppl):55\u201369. https:\/\/doi.org\/10.56786\/PHWR.2025.18.11suppl.5.","DOI":"10.56786\/PHWR.2025.18.11suppl.5"},{"key":"4803_CR7","doi-asserted-by":"publisher","unstructured":"Liu J, Shen M, Zhuang G, Zhang L. Investigating the temporal trends of diabetes disease burden in China during 1990-2019 from a global perspective. Front Endocrinol. 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1324318.","DOI":"10.3389\/fendo.2024.1324318"},{"key":"4803_CR8","doi-asserted-by":"publisher","unstructured":"Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S, et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2025. https:\/\/doi.org\/10.1016\/s2213-8587(25)00299-2.","DOI":"10.1016\/s2213-8587(25)00299-2"},{"key":"4803_CR9","doi-asserted-by":"publisher","unstructured":"Du Q, Wang L, Long Q, Zhao Y, Abdullah AS. Systematic review and meta-analysis: Prevalence of diabetes among patients with tuberculosis in China. Trop Med Int Health. 2021;26(12):1553-9. https:\/\/doi.org\/10.1111\/tmi.13686.","DOI":"10.1111\/tmi.13686"},{"key":"4803_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"MA Baker","year":"2011","unstructured":"Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81. https:\/\/doi.org\/10.1186\/1741-7015-9-81.","journal-title":"BMC Med"},{"issue":"1","key":"4803_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90664-y","volume":"11","author":"N You","year":"2021","unstructured":"You N, Pan H, Zeng Y, Lu P, Zhu L, Lu W, et al. A risk score for prediction of poor treatment outcomes among tuberculosis patients with diagnosed diabetes mellitus from eastern China. Sci Rep. 2021;11(1):11219. https:\/\/doi.org\/10.1038\/s41598-021-90664-y.","journal-title":"Sci Rep"},{"issue":"6","key":"4803_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/cid\/ciab598","volume":"74","author":"LS Peetluk","year":"2022","unstructured":"Peetluk LS, Rebeiro PF, Ridolfi FM, Andrade BB, Cordeiro-Santos M, Kritski A, et al. A clinical prediction model for unsuccessful pulmonary tuberculosis treatment outcomes. Clin Infect Dis. 2022;74(6):973\u201382. https:\/\/doi.org\/10.1093\/cid\/ciab598.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4803_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jiph.2024.02.012","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang F, Zhang F, Li L, Pang Y. Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis. J Infect Public Health. 2024;17(4):632\u201341. https:\/\/doi.org\/10.1016\/j.jiph.2024.02.012.","journal-title":"J Infect Public Health"},{"key":"4803_CR14","doi-asserted-by":"publisher","unstructured":"Ma JB, Zeng LC, Ren F, Dang LY, Luo H, Wu YQ, et al. Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis. BMC Infect Dis. 2023;23(1). https:\/\/doi.org\/10.1186\/s12879-023-08193-0.","DOI":"10.1186\/s12879-023-08193-0"},{"key":"4803_CR15","doi-asserted-by":"publisher","unstructured":"Ye Z, Bai G, Yang L, Zhuang L, Li L, Li Y, et al. Development and validation of early alert model for diabetes mellitus-tuberculosis comorbidity. Microorganisms. 2025;13(4). https:\/\/doi.org\/10.3390\/microorganisms13040919.","DOI":"10.3390\/microorganisms13040919"},{"key":"4803_CR16","doi-asserted-by":"publisher","unstructured":"Lu B, Shi Y, Wang M, Jin C, Liu C, Pan X, et al. Development of a clinical prediction model for poor treatment outcomes in the intensive phase in patients with initial treatment of pulmonary tuberculosis. Front Med. 2025;12. https:\/\/doi.org\/10.3389\/fmed.2025.1472295.","DOI":"10.3389\/fmed.2025.1472295"},{"issue":"2","key":"4803_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jdiacomp.2015.11.014","volume":"30","author":"Z Wu","year":"2016","unstructured":"Wu Z, Guo J, Huang Y, Cai E, Zhang X, Pan Q, et al. Diabetes mellitus in patients with pulmonary tuberculosis in an aging population in Shanghai, China: prevalence, clinical characteristics and outcomes. J Diabetes Complications. 2016;30(2):237\u201341. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.11.014.","journal-title":"J Diabetes Complications"},{"issue":"10","key":"4803_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1365-3156.2012.03069.x","volume":"17","author":"Y Lin","year":"2012","unstructured":"Lin Y, Li L, Mi F, Du J, Dong Y, Li Z, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health. 2012;17(10):1302\u20138. https:\/\/doi.org\/10.1111\/j.1365-3156.2012.03069.x.","journal-title":"Trop Med Int Health"},{"issue":"12","key":"4803_CR19","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.5588\/ijtld.18.0340","volume":"22","author":"R van Crevel","year":"2018","unstructured":"van Crevel R, Koesoemadinata R, Hill PC, Harries AD. Clinical management of combined tuberculosis and diabetes. Int J Tuberc Lung Dis. 2018;22(12):1404\u201310. https:\/\/doi.org\/10.5588\/ijtld.18.0340.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"4803_CR20","doi-asserted-by":"publisher","DOI":"10.3892\/mi.2023.128","volume":"4","author":"YF Peng","year":"2024","unstructured":"Peng YF. Pulmonary tuberculosis and diabetes mellitus: epidemiology, pathogenesis and therapeutic management (review). Med Int (Lond). 2024;4(1):4. https:\/\/doi.org\/10.3892\/mi.2023.128.","journal-title":"Med Int (Lond)"},{"issue":"6","key":"4803_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/cid\/cir939","volume":"54","author":"MA Baker","year":"2012","unstructured":"Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis. 2012;54(6):818\u201325. https:\/\/doi.org\/10.1093\/cid\/cir939.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4803_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12762","volume":"152","author":"P Kumar Nathella","year":"2017","unstructured":"Kumar Nathella P, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13\u201324. https:\/\/doi.org\/10.1111\/imm.12762.","journal-title":"Immunology"},{"key":"4803_CR23","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2147\/idr.s217044","volume":"12","author":"W-m Song","year":"2019","unstructured":"Song W-m, Shao Y, Liu J-y, Tao N-n, Liu Y, Zhang Q-y, et al. Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China. Infect Drug Resist. 2019;12:2397\u2013407. https:\/\/doi.org\/10.2147\/idr.s217044.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"4803_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00180-19","volume":"35","author":"N Dookie","year":"2022","unstructured":"Dookie N, Ngema SL, Perumal R, Naicker N, Padayatchi N, Naidoo K. The changing paradigm of drug-resistant tuberculosis treatment: successes, pitfalls, and future perspectives. Clin Microbiol Rev. 2022;35(4):e0018019. https:\/\/doi.org\/10.1128\/cmr.00180-19.","journal-title":"Clin Microbiol Rev"},{"key":"4803_CR25","doi-asserted-by":"publisher","unstructured":"Cai X, Xu X, He G, Jiang X, Wu L. Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysis. BMC Infect Dis. 2024;24(1). https:\/\/doi.org\/10.1186\/s12879-024-09712-3.","DOI":"10.1186\/s12879-024-09712-3"},{"key":"4803_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1386124","volume":"11","author":"F Tong","year":"2024","unstructured":"Tong F, Lai J, Lu Z, Bao Z, Cao J. Clinical features, immunologic parameter and treatment outcome of Chinese tuberculosis patients with or without DM. Front Med (Lausanne). 2024;11:1386124. https:\/\/doi.org\/10.3389\/fmed.2024.1386124.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"4803_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijtb.2020.09.020","volume":"68","author":"P Kuruva","year":"2021","unstructured":"Kuruva P, Kandi SR, Kandi S. Clinico-radiological profile and treatment outcome of pulmonary tuberculosis with and without type 2 diabetes mellitus. Indian J Tuberc. 2021;68(2):249\u201354. https:\/\/doi.org\/10.1016\/j.ijtb.2020.09.020.","journal-title":"Indian J Tuberc"},{"key":"4803_CR28","doi-asserted-by":"publisher","unstructured":"Barot A, Vora A, Dobariya O, Parikh V, Rahumath SL, Shah N, et al. Clinicoradiological profile of patients having drug-sensitive pulmonary tuberculosis with and without diabetes mellitus in a tertiary care hospital in Ahmedabad, Gujarat. India Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.58810.","DOI":"10.7759\/cureus.58810"},{"issue":"2","key":"4803_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4239\/wjd.v15.i2.196","volume":"15","author":"H Shi","year":"2024","unstructured":"Shi H, Yuan Y, Li X, Li Y-F, Fan L, Yang X-M. Analysis of the influencing factors and clinical related characteristics of pulmonary tuberculosis in patients with type 2 diabetes mellitus. World J Diabetes. 2024;15(2):196\u2013208. https:\/\/doi.org\/10.4239\/wjd.v15.i2.196.","journal-title":"World J Diabetes"},{"issue":"3","key":"4803_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121698","volume":"10","author":"CY Chiang","year":"2015","unstructured":"Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, et al. The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PLoS ONE. 2015;10(3):e0121698. https:\/\/doi.org\/10.1371\/journal.pone.0121698.","journal-title":"PLoS ONE"},{"key":"4803_CR31","doi-asserted-by":"publisher","unstructured":"Widihastuti A, Sirait RH, Simatupang A, Idhayu AT. Effect of poor glycemic control with length of pulmonary tuberculosis treatment in type 2 diabetes mellitus patients. Indones J Clin Pharm. 2023;12(1). https:\/\/doi.org\/10.15416\/ijcp.2023.12.1.1.","DOI":"10.15416\/ijcp.2023.12.1.1"},{"issue":"7","key":"4803_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-014-0505-1","volume":"14","author":"ME Jorgensen","year":"2014","unstructured":"Jorgensen ME, Faurholt-Jepsen D. Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review. Curr Diab Rep. 2014;14(7):505. https:\/\/doi.org\/10.1007\/s11892-014-0505-1.","journal-title":"Curr Diab Rep"},{"issue":"2","key":"4803_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ijtb.2024.03.013","volume":"72","author":"D Landis","year":"2025","unstructured":"Landis D, Sutter A, Nugent K. The effect of glycated hemoglobin trajectories on outcomes in patients with pulmonary tuberculosis in India. Indian J Tuberc. 2025;72(2):273\u20134. https:\/\/doi.org\/10.1016\/j.ijtb.2024.03.013.","journal-title":"Indian J Tuberc"},{"key":"4803_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-15-3","volume":"15","author":"YH Lin","year":"2015","unstructured":"Lin YH, Chen CP, Chen PY, Huang JC, Ho C, Weng HH, et al. Screening for pulmonary tuberculosis in type 2 diabetes elderly: a cross-sectional study in a community hospital. BMC Public Health. 2015;15:3. https:\/\/doi.org\/10.1186\/1471-2458-15-3.","journal-title":"BMC Public Health"},{"key":"4803_CR35","doi-asserted-by":"publisher","unstructured":"Castro AT, Mendes M, Freitas S, Roxo PC. Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years. Rev Port Pneumol (2006). 2015;21(3):144\u201350. https:\/\/doi.org\/10.1016\/j.rppnen.2014.08.004.","DOI":"10.1016\/j.rppnen.2014.08.004"},{"key":"4803_CR36","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Gonz\u00e1lez JA, Mart\u00ednez-Soto JM, Avila-Cervantes C, Mata-Pineda AL, \u00c1lvarez-Hern\u00e1ndez G, \u00c1lvarez-Meza JB, et al. Evaluation of systemic inflammation before and after standard anti-tuberculosis treatment in patients with active pulmonary tuberculosis and diabetes mellitus. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.55391.","DOI":"10.7759\/cureus.55391"},{"key":"4803_CR37","doi-asserted-by":"publisher","unstructured":"Brake J, Ajie M, Sumpter NA, Koesoemadinata RC, Soetedjo NNM, Santoso P, et al. Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study. iScience. 2025;28(6):112760. https:\/\/doi.org\/10.1016\/j.isci.2025.112760.","DOI":"10.1016\/j.isci.2025.112760"},{"key":"4803_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1556857","volume":"16","author":"Y Ji","year":"2025","unstructured":"Ji Y, Xie Q, Wei W, Huang Z, Liu X, Ye Q, et al. Association between blood inflammatory status and the survival of tuberculosis: a five-year cohort study. Front Immunol. 2025;16:1556857. https:\/\/doi.org\/10.3389\/fimmu.2025.1556857.","journal-title":"Front Immunol"},{"key":"4803_CR39","doi-asserted-by":"publisher","unstructured":"Mitroi DM, Balteanu MA, Cioboata R, Vlasceanu SG, Zlatian OM, Catana OM, et al. Hypercoagulability in tuberculosis: pathophysiological mechanisms, associated risks, and advances in management-a narrative review. J Clin Med. 2025;14(3). https:\/\/doi.org\/10.3390\/jcm14030762.","DOI":"10.3390\/jcm14030762"},{"key":"4803_CR40","doi-asserted-by":"publisher","unstructured":"Franco JVA, Bongaerts B, Metzendorf M-I, Risso A, Guo Y, Pe\u00f1a Silva L, et al. Undernutrition as a risk factor for tuberculosis disease. Cochrane Database System Rev. 2024;2025(3). https:\/\/doi.org\/10.1002\/14651858.CD015890.pub2.","DOI":"10.1002\/14651858.CD015890.pub2"},{"key":"4803_CR41","doi-asserted-by":"publisher","unstructured":"Tan J, Shi X, Pi Y, Xiang M, Li T. Nutritional scores predict the prognosis of patients with pulmonary tuberculosis. Front Nutr. 2024;11. https:\/\/doi.org\/10.3389\/fnut.2024.1454207.","DOI":"10.3389\/fnut.2024.1454207"},{"key":"4803_CR42","doi-asserted-by":"publisher","unstructured":"Koo H-K, Min J, Kim HW, Lee J, Kim JS, Park JS, et al. Prediction of treatment failure and compliance in patients with tuberculosis. BMC Infect Dis. 2020;20(1). https:\/\/doi.org\/10.1186\/s12879-020-05350-7.","DOI":"10.1186\/s12879-020-05350-7"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04803-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:12:04Z","timestamp":1779189124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04803-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4803"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04803-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the Helsinki Declaration and were approved by the Ethics Committee of the Liuzhou People\u2019s Hospital Affiliated to Guangxi Medical University (NO.KY2025-194\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}